about
Incidence of sudden cardiac death in a young active populationSystemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types.Transthyretin-related amyloidoses and the heart: a clinical overview.Cardiac involvement in hereditary-transthyretin related amyloidosis.Echocardiography in cardiac amyloidosis.Magnetic Resonance in Transthyretin Cardiac Amyloidosis.Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.Changing epidemiology of AA amyloidosis: clinical observations over 25 years at a single national referral centre.High prevalence of recurrent nocturnal desaturations in systemic AL amyloidosis: a cross-sectional pilot study.Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role.How to image cardiac amyloidosis.Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective.Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis.Gender-related risk of myocardial involvement in systemic amyloidosis.Diflunisal therapy for cardiac ATTR amyloidosis: a longitudinal, prospective, single centre study.Safety and efficacy of ezetimibe with low doses of simvastatin in heart transplant recipients.Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis.Carpal Tunnel Biopsy Identifying Transthyretin Amyloidosis.Left atrial structure and function in cardiac amyloidosis.Rapid hematological responses improve outcomes in patients with very advanced (Stage IIIb) cardiac immunoglobulin light chain amyloidosis.Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths.Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid.Defining the diagnosis in echocardiographically suspected senile systemic amyloidosis.Prognostic stratification and treatment of cardiac light chain amyloidosis: a narrow path in the jungleHigh 99mTc-DPD myocardial uptake in a patient with apolipoprotein AI-related amyloidotic cardiomyopathyNew pathological insights into cardiac amyloidosis: implications for non-invasive diagnosisRole of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosisUsefulness and limitations of 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in the aetiological diagnosis of amyloidotic cardiomyopathyA good clonal response to chemotherapy in AL amyloidosis is associated with improved quality of life and function at 1 yearCardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic RolesIdentification of TTR-Related Subclinical Amyloidosis With 99mTc-DPD ScintigraphyLongitudinal strain imaging in light-chain cardiac amyloidosis: can it help to refine the approach to treatment?Cardiac amyloidosisV122I transthyretin variant in elderly black AmericansNative T1 and Extracellular Volume in Transthyretin Amyloidosis
P50
Q28390745-8031ACA0-C975-4591-9AAD-88BD2ED027E6Q35002777-52C032B4-FFE0-4346-9C4F-157629D3B705Q37755977-2CAFC0D0-793F-4084-AC48-26BF44181AB8Q38001756-AC306EBC-EA3B-4E46-A1F7-73AE955E1AB7Q38322136-8FC12D3F-86DD-407B-8E92-498E3BE24E1DQ38400944-E6A2966B-60F0-4230-9AA1-1648340B77B8Q38414834-50744B76-31F8-4F65-BAA0-896955456FA3Q38689671-7EB8CE2F-1E18-41B5-9C3E-D23B56BF7FDFQ38862114-A831E7E8-98F3-4929-BE6F-B67348CD5BDBQ41724575-D42B581E-08C8-470B-B85E-DD50D9CB1EF5Q41867190-27C5E6FC-5D58-4D54-B52D-C3DAA1EE89BEQ43598098-6A492295-C410-4DAE-8A62-0D2DA5FE7297Q43984985-A4F829E4-D957-4952-931C-4802A30D221FQ44135752-3B58904B-EFB4-400A-8143-05D57D916FEDQ45851328-DA30821C-A1C3-44C7-9CD5-101B2ADA4B12Q46574915-28F4F54E-93A7-44E7-9C3C-E15265BD0714Q46902810-9F11946D-7B46-472A-B38F-E852AF0905A8Q48361513-7FEE12F8-4EFC-4F6E-86CD-00EDFBB7E925Q48548410-723E2FBC-2CE9-430D-848E-61AF6FE09E9BQ50158376-BEB8C5F3-1DC0-4253-8498-101090F0DD68Q50212765-0DC659D1-B301-4013-88FF-8FCE93CBDBC7Q50622497-B1D6060F-4550-45A7-9D70-C33C9351EF1BQ50912427-C62147A3-0EA2-49E2-BB67-8B7A072109BFQ53772437-A0B4AF70-454A-44C7-9B88-91868EAB1452Q56975555-006EA59A-BB76-4529-910D-E9909D2AAC04Q56978872-BCA508E2-595F-4681-A9B9-AAF90103EC86Q56981390-FA6A5285-FE1E-4C20-AE5C-285F4B8A2A03Q56985661-8C689717-9F69-4509-802E-C9646CF53DCAQ56986496-C2BA71BC-BD87-465A-89F3-C1272A7EF9F5Q58275488-558EBA65-2C2F-448B-BE17-6DE4D6147AAFQ61657807-2331A4B8-82EA-4707-922E-C68D24F24F84Q62083156-5499588C-30E5-4541-B7F4-428DCC0170A9Q84774216-1525B0B4-D096-4340-9B65-711BBEE62F64Q84987578-77761B0A-3CF4-4D08-88D9-9EB3B7A02193Q87210977-F05F74BC-B701-4C4E-986D-88318E4803DAQ88088242-3E4F487F-05C9-40BF-8C27-7C97928D7FED
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Candida Cristina Quarta
@ast
Candida Cristina Quarta
@en
Candida Cristina Quarta
@es
Candida Cristina Quarta
@nl
type
label
Candida Cristina Quarta
@ast
Candida Cristina Quarta
@en
Candida Cristina Quarta
@es
Candida Cristina Quarta
@nl
prefLabel
Candida Cristina Quarta
@ast
Candida Cristina Quarta
@en
Candida Cristina Quarta
@es
Candida Cristina Quarta
@nl
P106
P1153
56619484400
P21
P31
P496
0000-0003-0935-2873